You are here

  • Home
  • Archive
  • Volume 11, Issue 4
  • High tumor mutational burden predicts favorable response to anti-PD-(L)1 therapy in patients with solid tumor: a real-world pan-tumor analysis

Article metrics

Article menu
Immunotherapy biomarkers
Original research
High tumor mutational burden predicts favorable response to anti-PD-(L)1 therapy in patients with solid tumor: a real-world pan-tumor analysis

 

Online download statistics by month:

Online download statistics by month: April 2023 to March 2026

AbstractFullPdf
Apr 2023430433128
May 2023407412200
Jun 2023342344142
Jul 202323523585
Aug 202322422669
Sep 202316116167
Oct 202321922177
Nov 202317417473
Dec 202313914180
Jan 202411411489
Feb 202410910952
Mar 2024214219110
Apr 202415215773
May 202412612659
Jun 202413614068
Jul 202411711955
Aug 2024949254
Sep 202411011084
Oct 20249093539
Nov 202413513759
Dec 202410810964
Jan 2025999951
Feb 202510511035
Mar 202511111157
Apr 202511011265
May 2025707053
Jun 2025535339
Jul 2025110
Aug 2025110
Mar 2026110
Total438744302527